2. Treatment of diabetes mellitus Flashcards

1
Q

How is blood glucose normally controlled?

A
  • Pancreas monitors blood glucose
  • The liver is central to controlling glucose levels

If blood glucose is low…..
Glucagon is released from α cells + upper GI to stimulate glycogen breakdown + gluconeogenesis in the liver

if blood glucose is high….
• Insulin is released from β cells to stimulates the liver, adipose and muscle to take up glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diabetes occurs when regulation of blood glucose is ______

A

Diabetes occurs when regulation of blood glucose is disrupted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diabetes symptoms?

A
Fatigue
Poor wound healing
Blurred vision
Thirst
Numb/tingling hands and feet
Sex porblems
Weight loss suddenly
Vaginal infections
Hunger
Frequent urination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Genetic influence on Type 2 diabetes?

A
  • Gene set that causes greater insulin resistance
  • Gene set that causes hunger
  • Gene set that makes islets cells in the pancreas wear out early, so cannot make enough insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type 1 diabetes:

  • onset?
  • Weight gain?
  • Ketone level association?
  • Treatment?
  • Duration of treatment?
A

Often diagnosed in childhood
Not associated with excess body weight
Often associated with higher than normal ketone levels at diagnosis
Treated with insulin injections or insulin pump
Cannot be controlled without taking insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Type 2 diabetes:

  • onset?
  • Weight gain?
  • Ketone level association?
  • Treatment?
  • Duration of treatment?
A

Usually diagnosed in over 30 year olds

Usually diagnosed in over 30 year olds

Often associated with high blood pressure and/or cholesterol levels at diagnosis

Is usually treated initially without

Sometimes possible to come off diabetes medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Progression from pre-diabetes to type 2 DM?

A
  • T2D - there is a natural progression from prediabetes to diabetes.
  • This is due to a disruption of an individual’s ability to metabolise glucose.
  • Might not yet appear to have diabetes but may have hyperinsulinemia due to lower insulin sensitivity
  • Full diabetes progresses when beta-cell failure surpasses a critical threshold usually ~90%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aim in type 1 DM treatment?

A

Aim in treating Type I diabetics - replacement therapy to normalize glucose levels 4-7 mM (pre- prandial/fasting).

Blood glucose levels >10 mM will overload the renal capacity and be detected in the urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Normal glucose level?

A

In normal individuals glucose level can rise higher but should be <7.8 mM two hours after a meal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is insulin given parenterally?

A
  • Insulin is administered parentally because it is a protein that would be destroyed/digested by the gut if taken orally.
  • For routine use it is given subcutaneously and by IV infusion in emergencies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name 4 different insulin formulations?

A

Insulin Lispro or Insulin Aspart

Neutral Protamine Hagedorn/Isophane Insulin

Insulin Glargine

Insulin Detemir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin Lispro or Insulin Aspart, what is it?

A

Rapid-acting soluble insulin: Insulin Lispro or Insulin Aspart, designer insulins that prevent dimer formation allowing more active monomers to be bioavailable and used rapidly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neutral Protamine Hagedorn/Isophane Insulin, what is it?

A

Neutral Protamine Hagedorn/Isophane Insulin is an intermediate-acting insulin that precipitates insulin into suspensions which slowly dissolve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulin Glargine, what is it?

A

Insulin Glargine is a longer acting designer Insulin which has decreased solubility at neutral pH - forms aggregates that slowly dissolve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin Detemir, what is it?

A

Insulin Detemir is a long-acting designer insulin with a fatty acid – this confers albumin binding, which slowly dissociates prolonging circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Use of insulin formulations in T1 and T2 DM’s?

A

Insulin is used type 1 diabetic patients
T1Ds require insulin replacement so an intermediate-acting preparation or a more long-acting analogue is often combined with a short-acting analogue taken before meals.

1/3rd of T2D and for some women with gestational diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the difference and benefits of fixed and flexible insulin regimens?

A
  • On a fixed dose insulin therapy, the amount of insulin taken at each meal will not vary from day to day.
  • A FIXED dose therapy can help to simplify the understanding of blood glucose results but does not offer the flexibility of how much carbohydrate patients choose to consume at each meal
  • FLEXIBLE insulin therapy is used for patients that really understand glucose metabolism and gives patients more control of what they eat and how they balance their blood glucose levels but will take time and commitment to learn how best to adjust insulin doses.
  • On a flexible insulin therapy patients choose how much insulin to inject at each meal and also allows doses to be varied in response to different carbohydrate quantities in meals.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Oral hypoglycemic tablets are used to…

A

Oral hypoglycemic tablets are used to alter glucose metabolism in T2Ds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Principal oral hypoglycemia agent used in T2Ds?

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Action of metformin on insulin

A

Potentiates residual insulin sensitivity by increasing insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Metformin actions of gluconeogenesis?

A

Acts to reduce gluconeogenesis in the liver, which is markedly increased in type 2 diabetes and opposes the action of glucagon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Actions of metformin?

A

Metformin can potentiate residual insulin by increasing insulin sensitivity
• Acts to reduce gluconeogenesis in the liver, which is markedly increased in type 2 diabetes and opposes the action of glucagon.
• Increases glucose uptake and utilisation in skeletal muscle
• Slightly delays carbohydrate absorption in the gut.
• Increases fatty acid oxidation - reducing circulating LDL and VLDL., which can help in obesity associated diabetes and atherosclerosis development
• Can encourage weight loss by suppressing appetite but can cause anorexia in rare cases.

23
Q

MoA of metformin?

A
  • Metformin alters energy metabolism
  • It acts on the mitochondria to change the ratio of AMP to ATP
  • ↑ AMP:ATP ratios activate AMP- activated protein kinase (cells metabolic master switch) .
  • Inhibits glucagon signaling and gluconeogenic pathways
  • AMPK increases transcription of genes important for glucose transport fatty oxidatin and inhibits fatty acid synthesis
  • Takes time due to regulating gene networks
24
Q

Name two drug classes of insulin seretagogues?

A

Sulphonylureas

Meglitinides

25
Q

Name 4 sulphonylureas?

A

Tolbutamide, Chlorpropamide, Glibenclamide, Glipizide

26
Q

Name 2 meglitinides?

A

Repaglinide and Nateglinide

27
Q

Sulphonylureas (e.g. Tolbutamide, Chlorpropamide, Glibenclamide, Glipizide):
Action?
Use?
Tolerance?

A

MoA: Interfere with beta cell ion channels to potentiate insulin secretion.

  • Well tolerated but can lead to weight gain by stimulating appetite.
  • Used in early stages of type 2 diabetes – as they require functional b cells
28
Q

Action of Sulphonylureas (e.g. Tolbutamide, Chlorpropamide, Glibenclamide, Glipizide):
Combined with other drugs?
Drug interactions?

A

• Can be combined with Metformin and Glitazones.

Drug interactions: Severe hypoglycaemia due to competition for metabolising enzymes, plasma binding proteins, and excretory pathways.

29
Q

Use of Meglitinides (e.g. Repaglinide and Nateglinide)?

Benefit?

A

Potentiates insulin secretion by blocking Katp channels to increased insulin release.
Lowered riks of hypoglycaemia due to shorter duration of activity so…. NEXT GENERATION OF SECRETAGOGUES

30
Q

MoA of sulphonylureas?

A
  • High affinity receptors for these drugs are present in b- cell membranes.
  • Block ATP-sensitive potassium channels in b- cells.
  • Causes beta cell depolarisation, which leads to insulin secretion.
  • Only work if b cells of the pancreas are functional.
31
Q

Name 2 thiazolidinediones

Hint: glitazones

A

Pioglitazone

Rosiglitazone

32
Q

What is the drug class of pioglitazone and rosiglitazone?
What is their effect?
MoA?
Side effects?

A

Class: Thiazolidinedione

Drug effects:

  1. Increases insulin sensitivity and lowers blood glucose in T2DM
  2. Reduces the amount of exogenous insulin needed
  3. Increases glucose uptake into muscle in response to insulin
  4. Reduces glucose and FFA concs

Side effects:

  • Weight gain
  • Fluid retention
  • Linked to bladder cancer, heart failure +osteoporotic fractures
33
Q

MoA of pioglitazone and rosiglitazone?

A

MoA:
Peroxisome proliferator activated receptor(PPAR)-gamma agonists. This is expressed in adipose tissue, muscle and liver. Promotes the transcription of genes important in insulin signalling, such as lipoprotein lipase, fatty acid transporters, Glut-4 and others

34
Q

Name 2 rapid acting insulin formulations?

A

Insulin lispro

Insulin aspart

35
Q

Name a intermediate acting insulin formulation used>

A

Neutral protamine hagedorn/ Isophane insulin

Aggregates in suspension that slowly dissolve from injections site

36
Q

What are the two long acting “peakless” insulin formulations used?

A

Insulin detemir

Insulin glargine

37
Q
For the "once daily" insulin regime, what is the...
Number of inj?
Time on inj?
Suitability?
Formulations used?
Meal time and content?
Required patient understanding?
A

Number of inj?
1

Time on inj?
Morning

Suitability?
T2D

Formulations used?
Long acting (glargine) OR intermediate (e.g. NPH)

Meal time and content?
Less flexible

Required patient understanding?
Basic

38
Q
For the "twice daily" insulin regime, what is the...
Number of inj?
Time on inj?
Suitability?
Formulations used?
Meal time and content?
Required patient understanding?
A

Number of inj?
2

Time on inj?
Morning and evening

Suitability?
T1D and T2D

Formulations used?
Short acting + intermediate

Meal time and content?
Less flexible

Required patient understanding?
basic

39
Q
For the "Basal bolus" insulin regime, what is the...
Number of inj?
Time on inj?
Suitability?
Formulations used?
Meal time and content?
Required patient understanding?
A

Number of inj?
Multiple

Time on inj?
Throughout the day

Suitability?
T1D, some T2D

Formulations used?
Intermediate/long acting + short acting

Meal time and content?
Flexible

Required patient understanding?
High

40
Q
For the "insulin pump" insulin regime, what is the...
Number of inj?
Time on inj?
Suitability?
Formulations used?
Meal time and content?
Required patient understanding?
A

Number of inj?
Semi-automated: As needed

Time on inj?
Throughout the day

Suitability?
T1D

Formulations used?
Short-acting

Meal time and content?
Flexible

Required patient understanding?
Med/high

41
Q

Name an alpha-glucoside inhibitor?

A

Acarbose

42
Q

Acarbose, (an alpha-glucoside inhibitor):
MoA?
Use?
Side effects?

A

Delays carbohydrate absorption in the small intestine reducing the postprandial spike in glucose

Use: T2D, in combination with other hypoglycemics

Side effects: Flatulence and diarrhoea

43
Q

Name 3 selective sodium glucose cotransport 2 (SGLT2) inhibitors?

“agliflozin”

A

Canagliflozin
Dapagliflozin
Empagliflozin

44
Q

When are SGLT2 inhibitors used?

A

Used in T2D as monotherapy when diet & exercise alone is not adequate for whom metformin is contraindicated or inappropriate.

45
Q

Action of SGLT2 inhibitors?
Benefits
Risks?

A
  • Block glucose reabsorption by the proximal tubule leading to therapeutic glucosuria
  • Controls glycaemia independently of insulin pathways

– Well tolerated, reduce weight and reduce systolic blood pressure

• Do not cause hypoglycaemia but associated with increased risk of urinary tract infections

46
Q

Name 2 examples of incretins?

A
  • Glucagon-like peptide-1 (GLP-1) is secreted by L-cells in the gut
  • Gastric inhibitory peptide (GIP) secreted by K-cells in gut
47
Q

Action of incretins (e.g. GIP, GLP-1)?

A

Incretins directly…

  • stimulate insulin biosynthesis and secretion
  • inhibit glucagon secretion in the pancreas
  • delay gastric emptying
  • increase cardiac output
  • increase satiety signals in the brain.

Incretins indirectly…

  • increase insulin sensitivity in the muscle
  • decrease gluconeogenesis in the liver
48
Q

Breakdown of incretins?

A

• Incretins are rapidly degraded by an enzyme called dipeptidyl peptidase-4 (DPP-4).

49
Q

Name 3 incretin mimetics?

A

Exenatide, Exenatide LAR, and Liraglutide

= analogs of exendin-4/GLP-1

50
Q

Difference between Exenatide, Exenatide LAR, and Liraglutide in their action as incretin mimetics?

A
  • Exenatide is given TWICE DAILY, but can cause nausea
  • Exenatide LAR is a long-acting release formulation that is administered WEEKLY and induces less nausea.
  • Liraglutide has an additional fatty side-chain that confers ALBUMIN BINDING and slows renal clearance.
51
Q

Incretin mimetics:
Use?
Administration?
Side effects?

A

Use?
• Incretin analogs lowers blood glucose after a meal by increasing insulin secretion and suppressing glucagon secretion.
• Used for type 2 diabetes in addition to oral agents to improve control and aid weight loss.

Admin?
• Given subcutaneously (SC) as peptide analogs.

Side effects?
• Can cause hypoglycemia and a range of gastrointestinal effects.

52
Q

What are the DPP-4 inhibitors?

“gliptins”

A

Sitagliptin: well tolerated and weight neutral

Vildagliptin: Not used in USA due to association with RTI, headache and pancreatitis

53
Q

Role of DPP-4 inhibitors in diabetic treatment?

A

Enhances endogenous incretin effects by blocking DPP-4
–> Lowers blood glucose by increasing 1st phase of insulin response after meals

Use?
Used in type 2 diabetes in addition to other oral hypoglycaemic drugs.